Trial Profile
A multicentre, observational cohort study in patients with relapsing multiple sclerosis who switched from natalizumab to fingolimod or to interferon beta/glatiramer acetate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate; Interferon beta
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 26 Feb 2016 New trial record